Hongwu Sun | Nanobiotechnology | Best Researcher Award

Published on by Global Nano Awards

Prof. Hongwu Sun | Nanobiotechnology | Best Researcher Award

Third Military Medical University | China

Prof. Hongwu Sun is a leading researcher in nano-medicine, vaccine adjuvants, and translational pharmaceutical sciences, with sustained contributions spanning fundamental research, applied R&D, and innovation. His work focuses on the design of advanced nanocarriers, immunomodulatory adjuvants, and membrane-based delivery systems with applications in drug development and next-generation vaccines. According to Scopus, he has 906 citations across 46 documents, with an h-index of 18, reflecting strong scholarly impact and citation consistency. His research outputs include high-quality journal articles, conference publications, and scientific monographs, alongside extensive patent activity supporting pharmaceutical product transformation. He has led and contributed to nationally competitive research projects in drug innovation and biopharmaceutical development, resulting in multiple technologies translated toward industrial application. Prof. Hongwu Sun’s contributions extend to peer-review service for high-impact journals, editorial and evaluation roles, and leadership in academic conferences, underscoring his influence on research quality, innovation pathways, and the advancement of nano-enabled biomedical solutions.

Citation Metrics (Scopus)

1000

800

600

400

200

0

Citations
906

Documents
46

h-index
18

Citations

Documents

h-index

View Scopus Profile  View ORCID Profile  View ResearchGate  View Sci Profiles  View Loop Profile

Featured Publications

Agbaje Lateef | Nanobiotechnology | Outstanding Scientist Award

Published on by Global Nano Awards

Prof. Agbaje Lateef | Nanobiotechnology | Outstanding Scientist Award

Professor | Ladoke Akintola University of Technology (LAUTECH) | Nigeria

Prof. Agbaje Lateef is a globally recognized scholar in Industrial Microbiology, Biotechnology, and Nanobiotechnology, distinguished for his pioneering contributions to green nanotechnology and microbial valorization. With an exceptional research impact reflected in over 5,201 Scopus citations, 128 documents, 46 h-index, more than 160 peer-reviewed publications, influential book contributions, and multiple editorial roles, he ranks among the top 2% scientists globally (Elsevier–Stanford). His research has significantly advanced biogenic synthesis of metallic and metal-oxide nanoparticles, establishing cost-effective, eco-friendly approaches using microbial systems, agro-wastes, enzymes, and plant-based materials. These innovations contribute to diverse applications spanning biomedicine, environmental remediation, agriculture, water treatment, catalysis, and circular bioeconomy. He has demonstrated impactful findings on nanoparticle-enabled antimicrobial, antioxidant, anticancer, anticoagulant, larvicidal, antidiabetic, and nanofertilizer functions, offering transformative solutions for health, agriculture, and industry. A leading figure in Nigeria’s nanotechnology landscape, Prof. Agbaje Lateef is the Head of the Nanotechnology Research Group (NANO+), which has produced high-impact research outputs and consistently hosted national workshops and conferences since 2017. His scientometric studies have mapped Nigeria’s nanotechnology progress, shaping national visibility and research direction. His scholarly contributions include serving as Lead Editor of the authoritative book Microbial Nanobiotechnology: Principles and Applications (Springer, 2021), and co-editor of Microbiome and Nano-Cross-Talk: Sustainable Agriculture and Beyond (Elsevier, 2024). He has developed novel nanomaterials for wastewater treatment, corrosion inhibition, biomedical applications, and enhanced crop productivity. Prof. Agbaje Lateef’s work is supported by competitive national research grants, enabling breakthroughs in valorization of keratinous wastes, nanobiopesticides, nano-enabled aquaculture, and nanoparticle-mediated disease management. His research recognitions include prestigious awards for scholarly excellence and sustained global impact. He also provides extensive service as reviewer, editorial board member, and contributor to high-impact journals. Prof. Agbaje Lateef stands as a leading voice in advancing sustainable nanobiotechnology and shaping the future of microbial-based nanomaterial innovation.

Profiles: Scopus | ORCID | Google Scholar | ResearchGate | Web of Science | ScholarGPS | Exaly | Research Group Website 

Featured Publications

1. Adelere, I. A., & Lateef, A. (2016). A novel approach to the green synthesis of metallic nanoparticles: The use of agro-wastes, enzymes and pigments. Nanotechnology Reviews, 5(6), 567–587. https://doi.org/10.1515/ntrev-2016-0024

2. Lateef, A., Azeez, M. A., Asafa, T. B., Yekeen, T. A., Akinboro, A., Oladipo, I. C., Azeez, L., Ajibade, S. E., Ojo, S. A., Gueguim-Kana, E. B., & Beukes, L. S. (2016). Biogenic synthesis of silver nanoparticles using a pod extract of Cola nitida: Antibacterial, antioxidant activities and application as a paint additive. Journal of Taibah University for Science, 10(4), 551–562. https://doi.org/10.1016/j.jtusci.2015.10.010

3. Lateef, A., Adelere, I. A., Gueguim-Kana, E. B., Asafa, T. B., & Beukes, L. S. (2015). Green synthesis of silver nanoparticles using keratinase obtained from a strain of Bacillus safensis LAU 13. International Nano Letters, 5(1), 29–35. https://doi.org/10.1007/s40089-014-0133-4

4. Gueguim Kana, E. B., Oloke, J. K., Lateef, A., & Adesiyan, M. O. (2012). Modeling and optimization of biogas production on saw dust and other co-substrates using artificial neural network and genetic algorithm. Renewable Energy, 46, 276–281. https://doi.org/10.1016/j.renene.2012.03.027

5. Lateef, A., Oloke, J. K., Gueguim Kana, E. B., Oyeniyi, S. O., Onifade, O. R., Oyeleye, A. O., Oladosu, O. C., & Oyelami, A. O. (2008). Improving the quality of agro-wastes by solid-state fermentation: Enhanced antioxidant activities and nutritional qualities. Biotechnology Letters, 24, 2369–2374. https://doi.org/10.1007/s10529-008-9795-4

Muneeb Ullah | Nanobiotechnology | Best Paper Award

Published on by Global Nano Awards

Mr. Muneeb Ullah | Nanobiotechnology | Best Paper Award

PhD Student | Pusan National University | South Korea

Mr. Muneeb Ullah is an accomplished nanomedicine researcher specializing in pharmaceutical nanotechnology, drug delivery systems, and biomaterials for therapeutic applications. His research primarily focuses on the synthesis and characterization of nanoparticles for wound healing, colorectal cancer, diabetic wound treatment, and inflammatory bowel diseases. He has published 38 scientific documents with 504 citations and an h-index of 11, reflecting strong and consistent contributions to high-impact biomedical research. Mr. Muneeb Ullah has authored numerous peer-reviewed journal papers and book chapters in leading outlets such as Chemical Engineering Journal, Small, Carbohydrate Polymer Technologies & Applications, European Polymer Journal, Journal of Pharmaceutical Investigation, and Current Problems in Cardiology. His works have collectively accumulated an impressive total impact factor exceeding 120. His notable contributions include advancements in nanoparticle-based therapeutics, 3D and 4D bioprinting, nanocarbon-based biomedical materials, and smart wound-healing systems. He has also co-authored multiple academic books and chapters published by CRC Press and Academic Press, covering topics such as fungal biotechnology, gastrointestinal inflammation, carbon dots, cancer nanomedicine, and nanotechnology in wound healing. His interdisciplinary collaborations have led to innovations in biofilm-associated therapies, tissue engineering, and targeted drug delivery systems. Recognized as a Best Researcher Award recipient in 2024 and 2025, Mr. Muneeb Ullah’s scholarly impact extends to editorial and reviewer services for international journals. His ongoing projects explore novel nanocluster adhesives, biopolymer-based nanostructures, and tumor-selective delivery mechanisms. Through his pioneering R&D initiatives, Mr. Muneeb Ullah continues to advance the frontiers of nanomedicine, combining pharmaceutical technology with molecular innovation to address complex biomedical challenges globally.

Profiles: Scopus | ResearchGate | Sci Profiles | Scholar GPS

Featured Publications

1. Safdar, M., Ullah, M., Hamayun, S., Wahab, A., Khan, S. U., Abdikakhorovich, S. A., Haq, Z. U., Mehreen, A., Naeem, M., Mustopa, A. Z., & Hasan, N. (2024). Microbiome miracles and their pioneering advances and future frontiers in cardiovascular disease. Current Problems in Cardiology, 49(9), 102686. https://doi.org/10.1016/j.cpcardiol.2024.102686

2. Khan, M. A., Khan, N., Ullah, M., Hamayun, S., Makhmudov, N. I., Mbbs, R., Safdar, M., Bibi, A., Wahab, A., Naeem, M., & Hasan, N. (2024). 3D printing technology and its revolutionary role in stent implementation in cardiovascular disease. Current Problems in Cardiology, 49(6), 102568. https://doi.org/10.1016/j.cpcardiol.2024.102568

3. Khan, S. U., Ullah, M., Saeed, S., Saleh, E. A. M., Kassem, A. F., Arbi, F. M., Wahab, A., Rehman, M., ur Rehman, K., Khan, D., … & Lu, K. (2024). Nanotherapeutic approaches for transdermal drug delivery systems and their biomedical applications. European Polymer Journal, 207, 112819. https://doi.org/10.1016/j.eurpolymj.2024.112819

4. Khan, S. U., Huang, Y., Ali, H., Ali, I., Ahmad, S., Khan, S. U., Hussain, T., Ullah, M., & Lu, K. (2024). Single-cell RNA sequencing (scRNA-seq): Advances and challenges for cardiovascular diseases (CVDs). Current Problems in Cardiology, 49(2), 102202. https://doi.org/10.1016/j.cpcardiol.2023.102202

5. Zeb, F., Mehreen, A., Naqeeb, H., Ullah, M., Waleed, A., Awan, U. A., Haider, A., & Naeem, M. (2024). Nutrition and dietary intervention in cancer: Gaps, challenges, and future perspectives. In Nutrition and Dietary Interventions in Cancer (pp. 281–307). Springer Nature Switzerland. https://doi.org/10.1007/978-3-031-55622-7_11

Sunny Kumar | Nanobiotechnology | Young Scientist Award

Published on by Global Nano Awards

Mr. Sunny Kumar | Nanobiotechnology | Young Scientist Award

Researcher, CSIR-Indian Institute Of Chemical Biology, India

Mr. Sunny Kumar is an emerging researcher in cancer biology and nanomedicine, recognized for his interdisciplinary contributions that bridge molecular oncology, tumor microenvironment studies, and nanotechnology-driven therapeutics. With an h-index of 6, 11 publications, and 148 citations (as indexed in Scopus), his research reflects both productivity and impact within translational cancer science. His primary research focuses on elucidating the molecular mechanisms underlying glioma, colorectal, and breast cancer progression, emphasizing protein quality control systems such as the ubiquitin-proteasome system and their regulatory influence on oncogenic signaling. Mr. Sunny Kumar has explored novel therapeutic targets like E3 ligases (CHIP), PD-1/PD-L1 pathways, and HAUSP-MDM2 axes, offering valuable insights for cancer immunotherapy and personalized treatment strategies. In addition to mechanistic studies, Mr. Sunny Kumar integrates nanobiotechnology and drug delivery innovation, developing nanoparticle-based formulations capable of crossing the blood–brain barrier for targeted glioma therapy. His research on dual-drug nanotherapeutics and carbon nanotube-based diagnostic platforms has contributed to the advancement of precision medicine approaches for difficult-to-treat cancers. He has published extensively as first or corresponding author in high-impact journals such as Genes & Diseases (IF 9.4), BBA-Molecular Cell Research (IF 3.7), International Journal of Pharmaceutics (IF 5.2), and Journal of Medicinal Chemistry (IF 6.8). His scholarly output also includes multiple book chapters with Springer and Taylor & Francis, covering cancer proteomics, personalized therapy, and nanotherapeutics. Mr. Sunny Kumar serves as a peer reviewer for reputed journals, including BBA–Reviews on Cancer and Experimental Cell Research, further demonstrating his engagement in the scientific community. His research exhibits a robust methodological framework, integrating cell and molecular biology, bioinformatics, animal models, and nanocarrier engineering. Collectively, Mr. Sunny Kumar’s scientific endeavors underscore a commitment to next-generation cancer therapeutics, aiming to translate molecular discoveries into clinically viable nanomedicine solutions for precision oncology.

Profile: Scopus | ORCID | Google Scholar | RsearchGate

Featured Publications

1. Kumar, S., Chatterjee, M., Ghosh, P., Ganguly, K. K., Basu, M., & Ghosh, M. K. (2023). Targeting PD-1/PD-L1 in cancer immunotherapy: An effective strategy for treatment of triple-negative breast cancer (TNBC) patients. Genes & Diseases, 10(4), 1318–1350.

2. Kumar, S., Basu, M., & Ghosh, M. K. (2022). Chaperone-assisted E3 ligase CHIP: A double agent in cancer. Genes & Diseases, 9(6), 1521–1555.

3. Kumar, S., Basu, M., Ghosh, P., Ansari, A., & Ghosh, M. K. (2023). COVID‐19: Clinical status of vaccine development to date. British Journal of Clinical Pharmacology, 89(1), 114–149.

4. Kumar, S., Basu, M., Ghosh, P., Pal, U., & Ghosh, M. K. (2023). COVID-19 therapeutics: Clinical application of repurposed drugs and futuristic strategies for target-based drug discovery. Genes & Diseases, 10(4), 1402–1428.

5. Ghosh, M. K., Kumar, S., Ganguly, K. K., Ghosh, P., Tabassum, S., Basu, B., & Basu, M. (2023). COVID-19 and cancer: Insights into their association and influence on genetic and epigenetic landscape. Epigenomics, 15(4), 227–248.

 

Parvathalu Kalakonda | Nanobiotechnology | Best Researcher Award

Published on by Global Nano Awards

Assist. Prof. Dr. Parvathalu Kalakonda | Nanobiotechnology | Best Researcher Award

Assistant Professor, Government City College (A), India

Dr. Parvathalu Kalakonda is a distinguished researcher specializing in nanomaterials, polymer nanocomposites, and energy-related functional materials. His research spans the green synthesis of mono-, bi-, and tri-metal nanoparticles for antibacterial and photocatalytic applications, development of carbon- and polymer-based thermoelectric materials, and multifunctional nanocomposite scaffolds for biomedical and electronic devices. He has made significant contributions in the design and fabrication of micro-fibrous silver-coated polymeric scaffolds, flexible AgNP/PVA nanocomposite films for water purification and wound care, and carbon-based hydrogel/aerogel nanocomposites for thermal, mechanical, and thermoelectric applications. Dr. Parvathalu Kalakonda’s work employs a diverse array of methodologies, including chemical, sol-gel, and green synthesis approaches for nanoparticle fabrication, along with advanced materials characterization techniques such as XRD, SEM, TEM, AFM, UV-Vis, FTIR, Raman spectroscopy, and ellipsometry. He has expertise in thermal and mechanical analysis using DSC, MDSC, DMA, and AC calorimetry, as well as electrical characterization using four-point probe measurements and custom-developed setups for conductivity studies. His research also explores optical meta-materials, spintronics, quantum dot systems, and metal-polymer hybrid films, integrating materials science with energy and biomedical applications. Dr. Parvathalu Kalakonda has authored numerous high-impact publications, contributed book chapters, and holds patents in multifunctional nanocomposite materials and electromagnetic-based device modeling. He serves as a reviewer and editorial board member for multiple international journals, including Polymer Engineering and Science, Materials Letters, Nanomaterials and Nanotechnology, and Journal of Composites and Biodegradable Polymers. With over 360 citations, 34 publications, and an h-index of 12, his work demonstrates strong scientific impact and leadership in advanced nanomaterials research. His contributions bridge fundamental nanoscience and practical device applications, particularly in sustainable water treatment, energy harvesting, and multifunctional biomedical devices. Dr. Parvathalu Kalakonda’s interdisciplinary approach, combining synthesis, characterization, and application of advanced nanomaterials, positioning him as a leading researcher in the field of functional nanocomposites and energy materials.

Profile: Scopus | ORCID | Google Scholar | ResearchGate | Sci Profiles | Academia | Kalakondananolab

Featured Publications

  • Kalakonda, P., Kathi, R., Ligory, M. G., Dabbeta, N., Madipoju, N., Mynepally, S., … Podila, B. B. (2024). Argyreia nervosa-driven biosynthesis of Cu–Ag bimetallic nanoparticles from plant leaves extract unveils enhanced antibacterial properties. Bioprocess and Biosystems Engineering, 1–13.

  • Kalakonda, P., Mandal, P., Laxmi Mynepally, S., Bashipangu, A., Kethavath, A., Khanam, S. J., … Podila, B. B. (2024). Comparison of multi-metallic nanoparticles as alternative antibacterial agents: Understanding the role of their antibacterial properties. Journal of Inorganic and Organometallic Polymers and Materials, 1–16.

  • Parvathalu, K., Rajitha, K., Chandrashekar, B., Sathvik, K., Pranay Bhasker, K., Sreenivas, B., … Bala Bhaskar, P. (2024). Biomimetic synthesis of copper nanoparticles using Tinospora cordifolia plant leaf extract for photocatalytic activity applications. Plasmonics, 19(2), 825–834.

  • Kalakonda, P., Bashipangu, A., Mandal, P., Khanam, S. J., Banovath, M., Hasan, I., & Podila, B. B. (2024). Sustainable solutions for clean water: Green synthesized Cu–Ag bimetallic nanoparticles based nano catalyst. Materials Science and Engineering: B, 301, 117147.

  • Kalakonda, P., Thodeti, M., Ganneboina, C., Ankathi, K., Kathri, S., Begari, K., … Podila, B. B. (2024). Eco-friendly fabrication of silver nanoparticles for sustainable water purification and antibacterial synergy. Plasmonics, 1–13.

 

Prof. Dr. Salvatore De-Simone | Nanobiotechnology Awards | Best Researcher Award

Published on by Global Nano Awards

Prof. Dr. Salvatore De-Simone | Nanobiotechnology Awards | Best Researcher Award

Prof. Dr. Salvatore De-Simone ,Oswaldo Cruz Institute (IOC),Brazil

Salvatore Giovanni De Simone is a prominent biochemist with a distinguished career in the fields of biotechnology, molecular biology, and infectious diseases. He earned his Bachelor of Science in Biomedical Sciences from the State of Rio de Janeiro University (1976), followed by a Master’s (1980) and Doctorate (1986) in Biochemistry from the Federal University of Rio de Janeiro. Throughout his career, Dr. De Simone has held various prestigious positions, including Full Professor of Biochemistry at the Federal Fluminense University and Chief of the Biochemistry of Protein and Peptides Laboratory at the Oswaldo Cruz Institute (FIOCRUZ). He has also served as a visiting researcher at several renowned international institutions. Currently, Dr. De Simone is a Specialist in Science and Technology Production and Innovation in Health at the Oswaldo Cruz Foundation and a member of the National Institute of Neglected Population Diseases of Brazil. His research focuses on antimicrobial peptides, protein structure, and immunological diagnostics, and he has published extensively on these topics. Dr. De Simone has supervised numerous graduate students and postdoctoral researchers and has coordinated significant national and international research projects and symposiums.

Professional Profile:

Scopus

Orcid

Suitability for the “Best Researcher Award” – Summary and Conclusion

Candidate: Salvatore Giovanni De Simone

Summary of Suitability: Salvatore Giovanni De Simone is an accomplished scientist with an extensive background in biochemistry, molecular biology, and infectious diseases. His career spans over four decades, highlighted by significant contributions to academia, research, and scientific innovation. De Simone has held prestigious positions, including Full Professor of Biochemistry at the Federal Fluminense University and Chief of the Biochemistry of Protein and Peptides Laboratory at the Oswaldo Cruz Institute. His work has led to numerous advancements in understanding and combating infectious diseases, particularly through the study of protein structures, antimicrobial peptides, and the development of diagnostic tools.

🎓Education:

Salvatore Giovanni De Simone holds a Bachelor of Science in Biomedical Sciences from the State of Rio de Janeiro University, completed in 1976. He further advanced his education by earning a Master of Science in Biochemistry in 1980, followed by a Doctor of Science in Biochemistry in 1986, both from the Federal University of Rio de Janeiro

🏢Work Experience:

Salvatore Giovanni De Simone has held numerous prestigious positions throughout his career. He is currently a Specialist in Science and Technology Production and Innovation in Health at the Center for Technological Development in Health (CDTS) at the Oswaldo Cruz Foundation in Rio de Janeiro, Brazil. Previously, he served as a Full Professor of Biochemistry at the Federal Fluminense University in Niterói, Rio de Janeiro, from 1984 to 2012. He also led the Biochemistry of Protein and Peptides Laboratory at the Oswaldo Cruz Institute (FIOCRUZ) from 1992 to 2012. In addition to his roles in Brazil, Dr. De Simone has gained international experience as a Visiting Researcher at the Laboratory of Genic Recombination at the Institut d’Hematologie-Centre Hayem, Hopital St. Louis in Paris, France, in 1987; at the Department of Medical Parasitology at New York University (NYU) in the United States from 1988 to 1989; and at the European Molecular Biology Laboratory (EMBL) in Germany in 1990.

🏅Awards and Honors:

Salvatore Giovanni De Simone has been recognized with several notable awards and positions throughout his career. He has received the Researcher Productivity Award (Category 1C) from the National Council of Scientific and Technological Development (CNPq) in Brazil and has been honored as a Scientist of the State of Rio de Janeiro by the Foundation for Research Support of the State of Rio de Janeiro (FAPERJ). Dr. De Simone also coordinated the Peptide Synthesis Platform at the Oswaldo Cruz Foundation from 1992 to 2012. Additionally, he served as a member of the Assessment Committee in Biotechnology for the National Council of Research from Brazil (CNPq) during the 2022-2023 term.

Publication Top Notes:

  • Title: Development of an Electrochemical Immunosensor for the Diagnostic Testing of Spotted Fever Using Synthetic Peptides
    • Citations: 18
  • Title: Cryptosporidium spp. Contamination in Perna perna Mussels Destined for Human Consumption in Southeastern Rio de Janeiro, Brazil
    • Citations: 7
  • Title: Ultrasensitive and Rapid Immuno-detection of Human IgE Anti-therapeutic Horse Sera Using an Electrochemical Immunosensor
    • Citations: 9
  • Title: Development of an ELISA for the Diagnosis of Reactive IgE Antibodies Anti-therapeutic Horse Sera
    • Citations: 10
  • Title: Oligopeptidase B and B2: Comparative Modelling and Virtual Screening as Searching Tools for New Antileishmanial Compounds
    • Citations: 11

 

 

 

 

Dr. Stalin Dhas | Nanobiotechnology Awards | Best Researcher Award

Published on by Global Nano Awards

Dr. Stalin Dhas | Nanobiotechnology Awards | Best Researcher Award

Dr. Stalin Dhas , Sathyabama Institute of Science and Technology (Deemed to be University) , India

Dr. T. Stalin Dhas is an accomplished researcher and Assistant Professor at the Centre for Ocean Research, Sathyabama Institute of Science & Technology in Chennai. He holds a Ph.D. in Life Sciences from Sathyabama University, where he received the Col. Dr. Jeppiaar Doctoral Excellence Award for his thesis on biologically synthesized gold nanoparticles using Sargassum species and their antidiabetic activity. With over 13 years of research experience and 3 years of teaching experience, Dr. Stalin Dhas has significantly contributed to the fields of nanotechnology and marine biotechnology. He has been involved in several funded research projects, including those supported by DST-SERB and MoES, focusing on the applications of nanoparticles in biomedical and aquatic health contexts. His academic background includes an M.Sc. and B.Sc. in Microbiology, both with high distinctions.

Professional Profile:

Scopus

Orcid

Google Scholar

🎓Education:

Dr. T. Stalin Dhas holds a Ph.D. in Life Sciences from Sathyabama University, Chennai, awarded in 2016 for his research on biologically synthesized gold nanoparticles using Sargassum spp. and their antidiabetic activity. His doctoral work earned him the prestigious Col. Dr. Jeppiaar Doctoral Excellence Award (Gold Medal) for Best Thesis. He also holds an M.Sc. in Microbiology from Sathyabama University, completed in 2009 with a CGPA of 8.54, earning him a First Class with Distinction. Dr. Stalin Dhas obtained his B.Sc. in Microbiology from R.V.S College of Arts & Science, Bharathiar University, Coimbatore, graduating in 2007 with a First Class. Additionally, he holds a Diploma in Computer Application from CSC Computer Education, Coimbatore, completed in 2007.

🏢Work Experience:

Dr. T. Stalin Dhas is currently an Assistant Professor (Research) at the Centre for Ocean Research, Sathyabama Institute of Science & Technology in Chennai, a position he has held since June 2014. Prior to this, he served as a Junior Research Fellow (JRF) at the same institution from August 2010 to May 2014. During his tenure as a JRF, he worked on a DST-Nanomission funded project focused on the biological synthesis of gold nanoparticles using Sargassum species for antidiabetic applications.

🏆Awards:

In 2016, Dr. T. Stalin Dhas was honored with the Col. Dr. Jeppiaar Doctoral Excellence Award (Gold Medal) for Best Thesis in recognition of his outstanding research on biologically synthesized gold nanoparticles using Sargassum species and their antidiabetic activity.

Publication Top Notes:

  • Title: The Potential of Dutasteride for Treating Multidrug-Resistant Candida auris Infection
    Cited by: Not available yet
  • Title: Antagonistic activity of a novel chitosan-selenium nanoflower against common aquaculture pathogen Aeromonas caviae
    Cited by: 1
  • Title: Optically active organic and inorganic nanomaterials for biological imaging applications: A review
    Cited by: 8
  • Title: Macroalgae-associated halotolerant marine bacteria Exiguobacterium aestuarii ADCG SIST3 synthesized gold nanoparticles and its anticancer activity in breast cancer cell line
    Cited by: 4
  • Title: Lipopeptide and rhamnolipid biosurfactant as biopesticides
    Cited by: 1